Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5ZQA

Crystal Structure of Penicillin-Binding Protein D2 from Listeria monocytogenes in the apo form

5ZQA の概要
エントリーDOI10.2210/pdb5zqa/pdb
分子名称Lmo2812 protein, MAGNESIUM ION, DI(HYDROXYETHYL)ETHER, ... (4 entities in total)
機能のキーワードlisteria monocytogenes, hypothetical, penicillin-binding protein, lmpbpd2, lmo2812, antibiotic
由来する生物種Listeria monocytogenes EGD-e
タンパク質・核酸の鎖数1
化学式量合計30270.64
構造登録者
Jeong, J.H.,Kim, Y.G. (登録日: 2018-04-18, 公開日: 2018-07-25, 最終更新日: 2023-11-22)
主引用文献Jeong, J.H.,Cha, H.J.,Kim, Y.G.
Crystal Structures of Penicillin-Binding Protein D2 from Listeria monocytogenes and Structural Basis for Antibiotic Specificity
Antimicrob. Agents Chemother., 62:-, 2018
Cited by
PubMed Abstract: β-Lactam antibiotics that inhibit penicillin-binding proteins (PBPs) have been widely used in the treatment of bacterial infections. However, the molecular basis underlying the different inhibitory potencies of β-lactams against specific PBPs is not fully understood. Here, we present the crystal structures of penicillin-binding protein D2 (PBPD2) from , a Gram-positive foodborne bacterial pathogen that causes listeriosis in humans. The acylated structures in complex with four antibiotics (penicillin G, ampicillin, cefotaxime, and cefuroxime) revealed that the β-lactam core structures were recognized by a common set of residues; however, the R1 side chains of each antibiotic participate in different interactions with PBPD2. In addition, the structural complementarities between the side chains of β-lactams and the enzyme were found to be highly correlated with the relative reactivities of penam or cephem antibiotics against PBPD2. Our study provides the structural basis for the inhibition of PBPD2 by clinically important β-lactam antibiotics that are commonly used in listeriosis treatment. Our findings imply that the modification of β-lactam side chains based on structural complementarity could be useful for the development of potent inhibitors against β-lactam-resistant PBPs.
PubMed: 30082290
DOI: 10.1128/AAC.00796-18
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.55 Å)
構造検証レポート
Validation report summary of 5zqa
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon